Skip to main content

Table 1 Evidence-informed deliberative processes used to elicit public preferences in Belgium and New Zealand

From: Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand

  1. Abbreviations: f2f face-to-face, KBF King Baudouin Foundation, KCE Belgium Health Care Knowledge Center, OOP Operating Policies and Procedures, PHARMAC Pharmaceutical Management Agency, RIZIV/INAMI Belgium National Institute for Health Insurance
  2. Note: in New Zealand the old funding decision criteria apply to in- and out-patient drugs; the new funding decision criteria apply to in- and out-patient drugs, devices and vaccines. In Belgium, funding decision criteria apply to out-patient drugs
  3. Sources: Evidence-informed deliberative framework modified from [20], KCE report 147C [24], KBF 2013 [33], KCE 195C [34], KCE 234 [35]